IDSA Media Briefing: Update on COVID-19 Treatment Guidelines

A COVID-19 briefing with experts from the Infectious Diseases Society of America to discuss recent updates to IDSA’s COVID-19 Treatment Guidelines:

• New recommendation re: monoclonal antibodies
• Updated recommendations for the use of tocilizumab
• 2021 treatment options and outlook
• Questions from the media

FEATURING:
Adarsh Bhimraj, MD, FIDSA—Cleveland, OH
Chair, IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Fellow—Infectious Diseases Society of America
Head of the Neurologic Infectious Diseases Section, Department of Infectious Diseases, Cleveland Clinic
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Rajesh T. Gandhi, MD, FIDSA—Boston, MA
Member, IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Chair—HIV Medicine Association
Professor of Medicine, Harvard Medical School
Director of HIV Clinical Services and Education, Massachusetts General Hospital

Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America